Publications

Detailed Information

Fas/Fas Ligand-mediated Apoptosis Promotes Hypersensitivity Pneumonitis in Mice by Enhancing Maturation of Dendritic Cells

DC Field Value Language
dc.contributor.authorHwang, Su Jin-
dc.contributor.authorKim, Hye Sung-
dc.contributor.authorChung, Doo Hyun-
dc.date.accessioned2012-06-28T01:42:36Z-
dc.date.available2012-06-28T01:42:36Z-
dc.date.issued2010-06-01-
dc.identifier.citationAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE; Vol.181 11; 1250-1261ko_KR
dc.identifier.issn1073-449X-
dc.identifier.urihttps://hdl.handle.net/10371/77711-
dc.description.abstractRationale: Fas/Fas ligand (FasL)-mediated apoptosis has been implicated in various lung diseases, but whether Fas/FasL-mediated apoptosis in the lungs plays a critical role in the development of hypersensitivity pneumonitis (HP) is unclear. Objectives: To explore the functional roles of Fas/FasL-mediated apoptosis in HP. Methods: Fas-deficient (lpr/lpr), FasL-deficient (gld/gld), and B6 mice were challenged with Saccharopolyspora rectivirgula (SR) antigen intranasally. Measurements and Main Results: lpr/lpr and gld/gld mice exhibited attenuation of HP in terms of histological alterations, influx of immune cells in bronchoalveolar lavage fluid (BALF), and SR-specific immune responses compared with B6 mice, similar to the effects of SR in B6 mice given a caspase inhibitor. The lungs of lpr/lpr and gld/gld mice showed high IL-4 production and low IFN-gamma, IL-8, macrophage inflammatory protein-2, IL-1 beta, and tumor necrosis factor-alpha production compared with those of B6 mice. Moreover, mice with chimeric B6 and lpr/lpr bone marrow revealed that apoptosis of nonhematopoietic and BALF immune cells of the lungs enhanced immune responses against SR antigen. Gr-1(+) granulocytes in BALF expressed annexin V and their depletion in B6 mice attenuated HP. Apoptosis of nonhematopoietic cells and Gr-1(+) granulocytes in the lungs enhanced the maturation of pulmonary CD11c(+) dendritic cells and their production of macrophage inflammatory protein-1 alpha and monocyte chemoattractant protein-1, resulting in recruitment of immune cells into the lungs during HP. Conclusions: These results suggest that apoptosis in nonhematopoietic cells and Gr-1(+) granulocytes of the lungs promotes HP by enhancing maturation and chemokine production of CD11c(+) dendritic cells.ko_KR
dc.language.isoenko_KR
dc.publisherAMER THORACIC SOCko_KR
dc.titleFas/Fas Ligand-mediated Apoptosis Promotes Hypersensitivity Pneumonitis in Mice by Enhancing Maturation of Dendritic Cellsko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor황수진-
dc.contributor.AlternativeAuthor김혜성-
dc.contributor.AlternativeAuthor정두현-
dc.identifier.doi10.1164/rccm.200909-1337OC-
dc.citation.journaltitleAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE-
dc.description.citedreferenceGirard M, 2009, EUR RESPIR J, V34, P749, DOI 10.1183/09031936.00140908-
dc.description.citedreferenceBarrios RJ, 2008, ARCH PATHOL LAB MED, V132, P199-
dc.description.citedreferenceMadison JM, 2008, ARCH PATHOL LAB MED, V132, P195-
dc.description.citedreferenceHWANG SJ, 2008, IMMUNE NETW, V8, P90-
dc.description.citedreferenceJohansson U, 2007, J IMMUNOL, V179, P1711-
dc.description.citedreferenceChan T, 2007, CANCER GENE THER, V14, P409, DOI 10.1038/sj.cgt.7701025-
dc.description.citedreferenceBeaty SR, 2007, J IMMUNOL, V178, P1882-
dc.description.citedreferenceHwang SJ, 2006, J IMMUNOL, V177, P5258-
dc.description.citedreferenceDemedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53-
dc.description.citedreferenceGuo ZH, 2005, BLOOD, V106, P2033, DOI 10.1182/blood-2004-12-4831-
dc.description.citedreferenceBertho N, 2005, BLOOD, V106, P1734, DOI 10.1182/blood-2004-10-3991-
dc.description.citedreferenceNance S, 2005, EUR J IMMUNOL, V35, P1928, DOI 10.1002/eji.200425762-
dc.description.citedreferencevan Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276-
dc.description.citedreferenceDemaria S, 2005, J LEUKOCYTE BIOL, V77, P361, DOI 10.1189/jlb.0804478-
dc.description.citedreferenceDosReis GA, 2004, J CELL MOL MED, V8, P285-
dc.description.citedreferencePark DR, 2003, J IMMUNOL, V170, P6209-
dc.description.citedreferenceLaflamme C, 2003, EUR RESPIR J, V21, P225, DOI 10.1183/09031936.03.00283903-
dc.description.citedreferenceDOSREIS GA, 2003, CURR DRUG TARGETS IN, V2, P161-
dc.description.citedreferenceSchuyler M, 2002, INT J EXP PATHOL, V83, P87, DOI 10.1046/j.1365-2613.2002.00217.x-
dc.description.citedreferenceNakashima K, 2001, IND HEALTH, V39, P269-
dc.description.citedreferenceMatute-Bello G, 2001, AM J PATHOL, V158, P153-
dc.description.citedreferenceKuwano K, 2000, INT ARCH ALLERGY IMM, V122, P209, DOI 10.1159/000024399-
dc.description.citedreferenceHagimoto N, 1999, AM J RESP CELL MOL, V21, P436-
dc.description.citedreferenceRovere P, 1998, J IMMUNOL, V161, P4467-
dc.description.citedreferenceGudmundsson G, 1998, J IMMUNOL, V161, P991-
dc.description.citedreferenceGudmundsson G, 1997, J CLIN INVEST, V99, P2386-
dc.description.citedreferenceHagimoto N, 1997, AM J RESP CELL MOL, V16, P91-
dc.description.citedreferenceGHADIRIAN E, 1992, MICROB PATHOGENESIS, V12, P377-
dc.description.tc1-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share